Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage

Kidney International

Volumn 71, Issue 10, 2007, Pages 967-970

  Mori, K ^a   Nakao, K ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Development; Gene expression; Iron; Ischemia reperfusion; Mesenchymal epithelial transition; Progression of renal failure; Siderophore

Indexed keywords

BIOLOGICAL MARKER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG; UVOMORULIN;

DISEASE MARKER; HUMAN; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PARENCHYMA; NEPHRON; NONHUMAN; POTENCY DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; SHORT SURVEY; TISSUE LEVEL; TRANSCRIPTION REGULATION;

ACUTE-PHASE PROTEINS; ANIMALS; BIOLOGICAL MARKERS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE; MOLECULAR STRUCTURE; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION, GENETIC;

EID: 34248345026     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002165     Document Type: Short Survey

References (41)

1. Flower DR, North AC, Sansom CE. The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta 2000; 1482: 9-24.
2. Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356-362.
3. Ragolia L, Palaia T, Hall CE et al. Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knockout mice. J Biol Chem 2005; 280: 29946-29955.
4. Hotamisligil GS, Johnson RS, Distel RJ et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996; 274: 1377-1379.
5. Goetz DH, Holmes MA, Borregaard N et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002; 10: 1033-1043.
6. Raymond KN, Dertz EA, Kim SS. Enterobactin: an archetype for microbial iron transport. Proc Natl Acad Sci USA 2003; 100: 3584-3588.
7. Barasch J, Mori K. Cell biology: iron thievery. Nature 2004; 432: 811-813.
8. Takahashi M, Nakanishi H, Kawasaki S et al. Enhanced tolerance of rice to low iron availability in alkaline soils using barley nicotianamine aminotransferase genes. Nat Biotechnol 2001; 19: 466-469.
9. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610-621.
10. Kjeldsen L, Johnsen AH, Sengelov H et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268: 10425-10432.
11. Yan L, Borregaard N, Kjeldsen L et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001; 276: 37258-37265.
12. Gwira JA, Wei F, Ishibe S et al. Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 2005; 280: 7875-7882.
13. Mori K, Yang J, Barasch J. Ureteric bud controls multiple steps in the conversion of mesenchyme to epithelia. Semin Cell Dev Biol 2003; 14: 209-216.
14. Barasch J, Yang J, Ware CB et al. Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell 1999; 99: 377-386.
15. Yang J, Goetz D, Li JY et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002; 10: 1045-1056.
16. Flo TH, Smith KD, Sato S et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004; 432: 917-921.
17. Li JY, Ram G, Gast K et al. Detection of intracellular iron by its regulatory effect. Am J Physiol Cell Physiol 2004; 287: C1547-C1559.
18. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520.
19. Supavekin S, Zhang W, Kucherlapati R et al. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003; 63: 1714-1724.
20. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534-2543.
21. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238.
22. Wagener G, Jan M, Kim M et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; 105: 485-491.
23. Mishra J, Mori K, Ma Q et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004; 15: 3073-3082.
24. Berger T, Togawa A, Duncan GS et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 2006; 103: 1834-1839.
25. Cowland JB, Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukoc Biol 1999; 66: 989-995.
26. Meheus LA, Fransen LM, Raymackers JG et al. Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J Immunol 1993; 151: 1535-1547.
27. Wang Y, Lam KS, Kraegen EW et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007; 53: 34-41.
28. Playford RJ, Belo A, Poulsom R et al. Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 2006; 131: 809-817.
29. Cowland JB, Sorensen OE, Sehested M et al. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003; 171: 6630-6639.
30. Hanai J, Mammoto T, Seth P et al. Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. J Biol Chem 2005; 280: 13641-13647.
31. Liu Q, Nilsen-Hamilton M. Identification of a new acute phase protein. J Biol Chem 1995; 270: 22565-22570.
32. Devireddy LR, Gazin C, Zhu X et al. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005; 123: 1293-1305.
33. Devireddy LR, Teodoro JG, Richard FA et al. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001; 293: 829-834.
34. Miharada K, Hiroyama T, Sudo K et al. Lipocalin 2 functions as a negative regulator of red lood cell production in an autocrine fashion. FASEB J 2005; 19: 1881-1883.
35. Park KM, Kramers C, Vayssier-Taussat M et al. Prevention of kidney ischemia/reperfusion-induced functional injury MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 2002; 277: 2040-2049.
36. Hvidberg V, Jacobsen C, Strong RK et al. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 2005; 579: 773-777.
37. Leheste JR, Rolinski B, Vorum H et al. Megalin knockout mice as an animal model of low molecular weight proteinuria. Am J Pathol 1999; 155: 1361-1370.
38. Moestrup SK, Verroust PJ. Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia. Annu Rev Nutr 2001; 21: 407-428.
39. Schmidt-Ott KM, Mori K, Kalandadze A et al. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006; 15: 442-449.
40. Fluckinger M, Haas H, Merschak P et al. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother 2004; 48: 3367-3372.
41. Holmes MA, Paulsene W, Jide X et al. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure 2005; 13: 29-41.